Annals of Tropical Medicine and Public Health
Home About us Ahead Of Print Instructions Submission Subscribe Advertise Contact e-Alerts Editorial Board Login 
Users Online:2211
  Print this page  Email this page Small font sizeDefault font sizeIncrease font size
 


 
Table of Contents   
LETTER TO THE EDITOR  
Year : 2017  |  Volume : 10  |  Issue : 4  |  Page : 1094-1095
What could be done in order to prevent antibiotic resistance nationally and internationally?


Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

Click here for correspondence address and email

Date of Web Publication5-Oct-2017
 

How to cite this article:
Tavana AM. What could be done in order to prevent antibiotic resistance nationally and internationally?. Ann Trop Med Public Health 2017;10:1094-5

How to cite this URL:
Tavana AM. What could be done in order to prevent antibiotic resistance nationally and internationally?. Ann Trop Med Public Health [serial online] 2017 [cited 2019 Sep 22];10:1094-5. Available from: http://www.atmph.org/text.asp?2017/10/4/1094/196759


Antimicrobial resistance is a public health concern due to not effective prevention and treatment in wide range of infections caused by bacteria (i.e., MDR-TB, XDR-TB), parasites (Malaria resistance to Chloroquine), viruses (i.e., HIV and Influenza A, H1N1), and fungi.[1],[2],[3] There are several mechanisms in implementation of bacteria resistance against antibiotics.[4] In this letter to editor I am not going to explain that. In fact, I am looking for several insufficient manual or protocol which leads to antibiotic resistance worldwide. The number of antibiotic resistance diseases has been increased sharply.[5] Noting can be done with previous protocol; perhaps much national and international antibiotic resistance must be revised not annually, but also monthly or even daily for each particular disease (i.e., Pneumococcal infection [6],[7],[8] or other agents.[9],[10]

Because the speed of antibiotic consumption for controlling of different infectious is fast too. Appropriate prescription of medicine by doctors and adequate consumption of that by patient and alert of antibiotic resistance by clinical laboratories must be monitored by health authorizes in order to prevent the problems of antibiotic resistance. Finally I would like to suggest creation of antibiotic resistance committee in all countries may be useful and that must be coordinate nationally and internationally by supervision of international health organization and exchange their opinion usually in order to prevent the mortality and morbidity related the problems anyway.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
http://www.who.int/mediacentre/factsheets/fs194/en. [Accessed on 2016 August 6].  Back to cited text no. 1
    
2.
https://en.wikipedia.org/wiki/Antimalarial_medication. [Accessed on 2016 August 6].  Back to cited text no. 2
    
3.
http://www.cdc.gov/fungal/antifungal-resistance.html. [Accessed on 2016 August 6].  Back to cited text no. 3
    
4.
Dever LA, Dermody TS. Mechanisms of bacterial resistance to antibiotics. Arch Intern Med 1991;151:886-95.  Back to cited text no. 4
    
5.
Hermsen R, Deris JB, Hwa T. On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient. Proc Nat Acad Sci USA 2012;109:10775-80.doi:10.1073/pnas.1117716109.  Back to cited text no. 5
    
6.
Mehrabi Tavana A, Ataee RA. Invasive pneumococcal disease (IPD) serotype frequency in Iranian patients. Iran Red Cres Med J 2013;15:740-42.doi:10.5812/ircmj.4145.  Back to cited text no. 6
    
7.
Tavana AM. Invasive pneumococcal disease (IPD) in Iranian patients and it's serotyping distribution in order to prevent the infection with suitable vaccine. Ann Trop Med Public Health 2013;6:684-5.  Back to cited text no. 7
  [Full text]  
8.
Habibian S, Mehrabi-Tavana A, Ahmadi Z, Izadi M, Jonaidi N, Darakhshanpoure J. et al. Serotype distribution and antibiotics susceptibility pattern of Streptococcus pneumonia in Iran. IRCMJ 2013;15-e8053.  Back to cited text no. 8
    
9.
Ataee RA, Mehrabi-Tavana A, Hosseini SMJ, Morid K, Ghorbananli Zadegan M. A method for antibiotic susceptibility testing: applicable and accurate. Jundishapur J Microbiol 2012;5:341-45.  Back to cited text no. 9
    
10.
Sanaei DA, Abdinia B, Karimi A. Nasopharyngeal carrier rate of Streptococcus pneumoniae in children: serotype distribution and antimicrobial resistance. Arch Iran Med 2012;15:500-3.  Back to cited text no. 10
    

Top
Correspondence Address:
Ali Mehrabi Tavana
Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1755-6783.196759

Rights and Permissions




 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *


    References

 Article Access Statistics
    Viewed732    
    Printed26    
    Emailed0    
    PDF Downloaded26    
    Comments [Add]    

Recommend this journal